Ameritas Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Sell |
8,157
-5,891
| -42% | -$273K | 0.02% | 573 |
|
|
2025
Q1 | $824K | Sell |
14,048
-1,759
| -11% | -$103K | 0.03% | 453 |
|
|
2024
Q4 | $894K | Buy |
15,807
+1,357
| +9% | +$76.8K | 0.03% | 447 |
|
|
2024
Q3 | $748K | Sell |
14,450
-785
| -5% | -$40.6K | 0.03% | 447 |
|
|
2024
Q2 | $633K | Sell |
15,235
-2,029
| -12% | -$84.3K | 0.02% | 519 |
|
|
2024
Q1 | $842K | Buy |
17,264
+9,334
| +118% | +$455K | 0.03% | 420 |
|
|
2023
Q4 | $399K | Sell |
7,930
-9,392
| -54% | -$472K | 0.02% | 480 |
|
|
2023
Q3 | $996K | Buy |
17,322
+9,961
| +135% | +$572K | 0.05% | 339 |
|
|
2023
Q2 | $461K | Sell |
7,361
-8,690
| -54% | -$544K | 0.06% | 313 |
|
|
2023
Q1 | $1.12M | Sell |
16,051
-5,373
| -25% | -$376K | 0.06% | 299 |
|
|
2022
Q4 | $1.54M | Buy |
21,424
+1,859
| +10% | +$134K | 0.07% | 262 |
|
|
2022
Q3 | $1.39M | Buy |
19,565
+338
| +2% | +$24K | 0.08% | 233 |
|
|
2022
Q2 | $1.48M | Buy |
19,227
+660
| +4% | +$50.8K | 0.09% | 227 |
|
|
2022
Q1 | $1.36M | Buy |
18,567
+421
| +2% | +$30.7K | 0.05% | 277 |
|
|
2021
Q4 | $1.13M | Buy |
+18,146
| New | +$1.13M | 0.04% | 314 |
|